Hot Life Science Investor Mandate 3: Venture Arm Focuses on Companies Developing New Drugs, Devices

31 Oct

The corporate venture arm of a larger foundation based in Europe has approximately $35 billion in AUM, provides (equity only) seed and venture capital to development stage companies, and also takes significant ownership positions in well-established companies within life science and biotechnology.

The firm will invest at any stage of development – seed, venture, and growth. They also make late-stage investments in public/private companies with a positive cash flow, and can allocate up to $40M or more depending on specific cases, but generally allocate between $5M and $20M. The firm seeks companies that are based in North America and Europe, but has no current mandate for the number of allocations it plans to make.

The venture arm is opportunistic in the life sciences space. Specifically, they focus on companies that specialize in the development of new drugs, new procedures for diagnosis and control of diseases, development of medical devices and instruments, and industrial biotechnology. They are very opportunistic in terms of subsectors and indications.

Currently, this particular firm is active in companies developing therapeutics and diagnostics targeting cardiovascular diseases, infectious diseases, immune disorders, diseases of the nervous system, mental and behavioral disorders, and cancer. Additionally, they have invested in companies developing therapeutics based on small molecules and antibodies. The firm has also made venture investments in companies developing medical technology in the area of reusable instruments, wound care, single use devices, therapeutic radiation devices, and active implantable devices.

 

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: